Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani

Featuring an interview with Dr Saad Zafar Usmani, including the following topics:

• Optimizing treatment intervention for patients with newly diagnosed multiple myeloma (MM) (0:00)
• Role of anti-CD38 antibodies in induction and maintenance therapy for patients with newly diagnosed disease (4:22)
• Case: A woman in her late 70s with revised International Staging System (R-ISS) Stage II IgG kappa myeloma who received D-Rd followed by maintenance daratumumab (14:02)
• Case: A man in his early 60s with double-hit myeloma who received D-KRd and carfilzomib maintenance therapy (26:10)
• Case: A man in his early 70s with R-ISS Stage III IgG kappa myeloma and translocation (4;14) who deferred transplant (33:24)
• Future directions in the management of MM (40:37)

CME information and select publications